Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Total Non-Current Liabilities (2017 - 2025)

Arcus Biosciences has reported Total Non-Current Liabilities over the past 9 years, most recently at $373.0 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $373.0 million for Q4 2025, down 26.57% from a year ago — trailing twelve months through Dec 2025 was $373.0 million (down 26.57% YoY), and the annual figure for FY2025 was $373.0 million, down 26.57%.
  • Total Non-Current Liabilities for Q4 2025 was $373.0 million at Arcus Biosciences, down from $386.0 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for RCUS hit a ceiling of $733.0 million in Q1 2022 and a floor of $260.1 million in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $497.0 million (2022), compared with a mean of $484.8 million.
  • Biggest five-year swings in Total Non-Current Liabilities: surged 646.09% in 2021 and later crashed 35.56% in 2025.
  • Arcus Biosciences' Total Non-Current Liabilities stood at $628.4 million in 2021, then fell by 19.96% to $503.0 million in 2022, then dropped by 2.39% to $491.0 million in 2023, then increased by 3.46% to $508.0 million in 2024, then dropped by 26.57% to $373.0 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $373.0 million (Q4 2025), $386.0 million (Q3 2025), and $367.0 million (Q2 2025) per Business Quant data.